Context Therapeutics Price Chart
Context Therapeutics Volume Chart
Context Therapeutics Market Segments
After Hours
+0.01(+0.54%)
| Open | $2.36 |
|---|---|
| Close | $2.37 |
| Low | $2.36 |
| Low Change | 0.00 (0.00%) |
| High | $2.39 |
| High Change | +0.03 (+1.27%) |
| Range | $0.03 |
| Volume | 1.708K |
| Dollar Volume | $4.05K |
Regular Trading Hours
-0.11(-4.44%)
| Open | $2.48 |
|---|---|
| Close | $2.37 |
| Low | $2.35 |
| Low Change | -0.13 (-5.24%) |
| High | $2.48 |
| High Change | +0.00 (+0.00%) |
| Range | $0.13 |
| Volume | 399.496K |
| Dollar Volume | $946.81K |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.04(+1.61%)
| Open | $2.48 |
|---|---|
| Close | $2.52 |
| Low | $2.46 |
| Low Change | -0.02 (-0.69%) |
| High | $2.52 |
| High Change | +0.04 (+1.61%) |
| Range | $0.06 |
| Volume | 1.235K |
| Dollar Volume | $3.11K |
Regular Trading Hours Yesterday
+0.09(+3.75%)
| Open | $2.40 |
|---|---|
| Close | $2.49 |
| Low | $2.38 |
| Low Change | -0.03 (-1.04%) |
| High | $2.51 |
| High Change | +0.11 (+4.58%) |
| Range | $0.14 |
| Volume | 274.028K |
| Dollar Volume | $682.33K |
Premarket Yesterday
-0.02(-0.83%)
| Open | $2.42 |
|---|---|
| Close | $2.40 |
| Low | $2.40 |
| Low Change | -0.02 (-0.83%) |
| High | $2.42 |
| High Change | +0.00 (+0.00%) |
| Range | $0.02 |
| Volume | 200 |
| Dollar Volume | $480.00 |
Context Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.39 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.37 |
| 20 Day Moving Average (SMA20) | $2.37 |
| 50 Day Moving Average (SMA50) | $2.62 |
| 100 Day Moving Average (SMA100) | $2.25 |
| 200 Day Moving Average (SMA200) | $1.63 |
Context Therapeutics Statistics
| Average Volume (30 Days) | 819.9K |
|---|---|
| P/E Ratio (Current) | -5.43 |
| EPS (Current) | -$0.44 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$32.82M |
| Cash Ratio | 8.34 |
| Current Ratio | 8.96 |
| Quick Ratio | 8.96 |
| Debt to Equity | 0.00 |
| Enterprise Value | $165.06M |
| EV to EBITDA | -3.79 |
| EV to Sales | — |
| Price to Book | 4.21 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.68% |
| Return on Equity | -0.77% |
Context Therapeutics Stock Splits
There have been no stock splits for Context Therapeutics (CNTX).
Context Therapeutics Dividends
There have been no dividends for Context Therapeutics (CNTX).